Insider · CIK 0001638469

Lengauer Christoph

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001638469

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-06-01	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,600 sh	—	—	9,600
2020-10-21	HOOKHOOKIPA Pharma Inc.A Award	Director	AAward	+4,603 sh	—	—	4,603
2020-06-18	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,600 sh	—	—	9,600
2019-12-18	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,600 sh	—	—	9,600
2019-04-17	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,924 sh	—	—	6,924
2016-04-13	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−15.9K sh	$20.01	−$318K	56,657
2016-04-12	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−10.3K sh	$20.01	−$206K	72,529
2016-04-11	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−8,537 sh	$20.30	−$173K	82,845
2016-03-24	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+12.5K sh	$1.49	+$18.6K	84,714
2016-03-24	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,668 sh	$1.87	+$12.5K	91,382
2016-03-24	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−12.5K sh	—	—	140,984
2016-03-24	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,668 sh	—	—	134,316
2016-02-03	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+40K sh	—	—	178,179
2015-12-17	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−6,463 sh	$25.14	−$162K	72,215
2015-12-16	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−24.2K sh	$25.03	−$605K	78,678
2015-12-15	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−500 sh	$25.00	−$12.5K	102,834
2015-11-03	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−36.7K sh	$20.98	−$771K	103,334
2015-11-02	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−48.3K sh	$21.10	−$1.02M	140,068

Recent filings

Accepted (ET)
Jun 44
Lengauer Christoph0001104659-21-077247
SEC(opens sec.gov)
Oct 234
Lengauer Christoph0001104659-20-117707
SEC(opens sec.gov)
Jun 194
Lengauer Christoph0001104659-20-075254
SEC(opens sec.gov)
Jan 34
Lengauer Christoph0001104659-20-000853
SEC(opens sec.gov)
Apr 244
Lengauer Christoph0001104659-19-023468
SEC(opens sec.gov)
Apr 144
Blueprint Medicines Corp0001179110-16-023067
SEC(opens sec.gov)
Apr 134
Blueprint Medicines Corp0001179110-16-023027
SEC(opens sec.gov)
Mar 284
Blueprint Medicines Corp0001179110-16-022256
SEC(opens sec.gov)
Feb 54
Blueprint Medicines Corp0001179110-16-018642
SEC(opens sec.gov)
Dec 174
Blueprint Medicines Corp0001179110-15-016448
SEC(opens sec.gov)
Nov 44
Blueprint Medicines Corp0001179110-15-014506
SEC(opens sec.gov)

Companies

Address

C/O BLUEPRINT MEDICINES CORPORATION 215 FIRST STREET

CAMBRIDGE, MA, 02142